These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34734710)

  • 1. Fine-Tuning Cas9 Activity with a Cognate Inhibitor AcrIIA4 to Improve Genome Editing in
    Jiang YH; Liu YF; Wang K; Zhou JY; Guo F; Zhao QW; Mao XM
    ACS Synth Biol; 2021 Nov; 10(11):2833-2841. PubMed ID: 34734710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strong and tunable anti-CRISPR/Cas activities in plants.
    Calvache C; Vazquez-Vilar M; Selma S; Uranga M; Fernández-Del-Carmen A; Daròs JA; Orzáez D
    Plant Biotechnol J; 2022 Feb; 20(2):399-408. PubMed ID: 34632687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
    Najah S; Saulnier C; Pernodet JL; Bury-Moné S
    BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a CRISPR/Cas9
    Ma JX; He WY; Hua HM; Zhu Q; Zheng GS; Zimin AA; Wang WF; Lu YH
    ACS Synth Biol; 2023 Oct; 12(10):3114-3123. PubMed ID: 37722085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-Layer Controls of Cas9 Activity Coupled With ATP Synthase Over-Expression for Efficient Genome Editing in
    Wang K; Zhao QW; Liu YF; Sun CF; Chen XA; Burchmore R; Burgess K; Li YQ; Mao XM
    Front Bioeng Biotechnol; 2019; 7():304. PubMed ID: 31737622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structure and dynamics of anti-CRISPR AcrIIA4, the Cas9 inhibitor.
    Kim I; Jeong M; Ka D; Han M; Kim NK; Bae E; Suh JY
    Sci Rep; 2018 Mar; 8(1):3883. PubMed ID: 29497118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cpf1-Assisted Multiplex Genome Editing and Transcriptional Repression in Streptomyces.
    Li L; Wei K; Zheng G; Liu X; Chen S; Jiang W; Lu Y
    Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 29980561
    [No Abstract]   [Full Text] [Related]  

  • 8. High-efficiency multiplex genome editing of Streptomyces species using an engineered CRISPR/Cas system.
    Cobb RE; Wang Y; Zhao H
    ACS Synth Biol; 2015 Jun; 4(6):723-8. PubMed ID: 25458909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precise Regulation of Cas9-Mediated Genome Engineering by Anti-CRISPR-Based Inducible CRISPR Controllers.
    Jain S; Xun G; Abesteh S; Ho S; Lingamaneni M; Martin TA; Tasan I; Yang C; Zhao H
    ACS Synth Biol; 2021 Jun; 10(6):1320-1327. PubMed ID: 34006094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas-Mediated Genome Editing of Streptomyces.
    Tan LL; Heng E; Zulkarnain N; Hsiao WC; Wong FT; Zhang MM
    Methods Mol Biol; 2022; 2479():207-225. PubMed ID: 35583741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome Editing: CRISPR-Cas9.
    Hoof JB; Nødvig CS; Mortensen UH
    Methods Mol Biol; 2018; 1775():119-132. PubMed ID: 29876814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of CRISPR-SpyCas9 inhibition by an anti-CRISPR protein.
    Dong D; Guo M; Wang S; Zhu Y; Wang S; Xiong Z; Yang J; Xu Z; Huang Z
    Nature; 2017 Jun; 546(7658):436-439. PubMed ID: 28448066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Efficiency Genome Editing of Streptomyces Species by an Engineered CRISPR/Cas System.
    Wang Y; Cobb RE; Zhao H
    Methods Enzymol; 2016; 575():271-84. PubMed ID: 27417933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision genome editing in the CRISPR era.
    Salsman J; Dellaire G
    Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
    Yang H; Patel DJ
    Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Cas12j for
    Tan LL; Heng E; Leong CY; Ng V; Yang LK; Seow DCS; Koduru L; Kanagasundaram Y; Ng SB; Peh G; Lim YH; Wong FT
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-step high-efficiency CRISPR/Cas9-mediated genome editing in Streptomyces.
    Huang H; Zheng G; Jiang W; Hu H; Lu Y
    Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):231-43. PubMed ID: 25739462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9 Technology in Translational Biomedicine.
    Leonova EI; Gainetdinov RR
    Cell Physiol Biochem; 2020 Apr; 54(3):354-370. PubMed ID: 32298553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disabling Cas9 by an anti-CRISPR DNA mimic.
    Shin J; Jiang F; Liu JJ; Bray NL; Rauch BJ; Baik SH; Nogales E; Bondy-Denomy J; Corn JE; Doudna JA
    Sci Adv; 2017 Jul; 3(7):e1701620. PubMed ID: 28706995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.